NCT06144606 2026-03-31Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)H. Lee Moffitt Cancer Center and Research InstitutePhase 2 Recruiting60 enrolled